---
layout: minimal-medicine
nav_exclude: true
title: Nivolumab
---

# Nivolumab

**Generic Name:** Nivolumab

**Usage:** Nivolumab is a type of immunotherapy medication, specifically a programmed death-1 (PD-1) inhibitor.  It's used to treat several types of cancers, including:

* **Advanced melanoma:**  Often used after other treatments have failed.
* **Non-small cell lung cancer (NSCLC):**  Used in certain stages and types of NSCLC, often in combination with other therapies.
* **Renal cell carcinoma (kidney cancer):**  Used in advanced stages.
* **Head and neck squamous cell carcinoma (HNSCC):**  Used after other treatments have failed.
* **Classical Hodgkin lymphoma:**  Used after other treatments have failed.
* **Urothelial carcinoma (bladder cancer):** Used in advanced stages.
* **Hepatocellular carcinoma (liver cancer):** Used in advanced stages.
* **Microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) cancers:**  Used in various types of cancers with this specific genetic characteristic.


**It is crucial to note that Nivolumab is not a first-line treatment for all these cancers.  Its use depends on the specific stage, type of cancer, and the patient's overall health. A doctor will determine the appropriate use based on individual circumstances.**


**Side Effects:**  Nivolumab can cause a wide range of side effects, some mild and others severe.  These can include:

* **Common side effects:** Fatigue, rash, itching, diarrhea, nausea, constipation, decreased appetite, cough, shortness of breath.
* **Serious side effects:**  These require immediate medical attention and can include:
    * **Infusion-related reactions:**  Allergic reactions during or after infusion.
    * **Pneumonitis (lung inflammation):**  Cough, shortness of breath, chest pain.
    * **Colitis (inflammation of the colon):**  Diarrhea, abdominal pain, bloody stools.
    * **Hepatitis (liver inflammation):**  Jaundice, abdominal pain, dark urine.
    * **Thyroid disorders:**  Hypothyroidism (underactive thyroid) or hyperthyroidism (overactive thyroid).
    * **Endocrine disorders:**  Problems with adrenal glands, pituitary gland, etc.
    * **Immune-related adverse events (irAEs):**  A broad category encompassing various organ-specific side effects due to the immune system's over-reaction.
    * **Kidney problems:**  Changes in kidney function.
* **Rare but serious side effects:**  Serious infections, autoimmune diseases.


**How it Works:** Nivolumab works by blocking the PD-1 protein on the surface of T cells (a type of immune cell). Cancer cells often use the PD-1 protein to evade the immune system. By blocking PD-1, Nivolumab helps to unleash the T cells to attack and destroy cancer cells.


**FAQs:**

* **How is Nivolumab administered?**  It's usually given intravenously (IV) by infusion over a period of time.
* **How long is the treatment course?** The duration of treatment varies depending on the type and stage of cancer and the patient's response to the medication.  It can range from several months to years.
* **What are the monitoring requirements?**  Regular blood tests and imaging scans are necessary to monitor for side effects and treatment response.
* **Are there interactions with other medications?**  Yes, there can be interactions with other medications.  It's essential to inform your doctor about all medications, supplements, and herbal remedies you are taking.
* **Is Nivolumab a cure for cancer?**  No, Nivolumab is not a cure for cancer, but it can help shrink tumors, slow the progression of the disease, and improve survival rates in some patients.
* **What are the costs associated with Nivolumab?** The cost can be substantial and varies depending on insurance coverage and other factors.


**Disclaimer:** This information is for general knowledge and does not constitute medical advice.  Always consult with a healthcare professional for any health concerns or before making any decisions related to your health or treatment.  They can provide personalized guidance based on your individual circumstances.


**Note:** This information is AI-generated or crowd-sourced and may not be accurate. Please consult a medical professional for verified advice.